Table 1.
Overview of the features of each trigeminal autonomic cephalalgia
Features | Cluster headache | Paroxysmal hemicrania | Hemicrania continua | SUNCT/SUNA |
---|---|---|---|---|
Gender ratio (male to female) | 3:1 | 1:1 | 1:2 | 1.5:1 |
Pain quality | Sharp/stab/throb | Sharp/stab/throb | Baseline—dull pain. During worsenings can be sharp/throb | Sharp/stab/throb |
Pain severity | Very severe | Very severe | Baseline—mild to moderate. Worsenings—moderate to severe | Severe |
Distribution of maximal pain | V1 > C2 > V2 > V3 | V1 > C2 > V2 > V3 | V1 > C2 > V2 > V3 | V1 > C2 > V2 > V3 |
Attacks per day | 1-8 | 1-40 | Daily in 50% | 1-100 |
Attack duration | 15-180 min | 2-30 min | 30 min to 3 days | 1-10 min |
Cranial autonomic features | Prominent and ipsilateral to pain | Prominent and ipsilateral to pain | Present during worsenings and can be bilateral | Prominent and ipsilateral to pain |
Restlessness during attack | 95% | 80% | 69% | 65% |
Circadian periodicity | Present | Absent | Absent | Absent |
Triggers | ||||
Alcohol | +++ | + | + | − |
Nitroglycerin | +++ | + | − | − |
Cutaneous | − | − | − | +++ |
Associated migraine features | ||||
Nausea | 50% | 40% | 53% | 10% |
Photophobia | 56% | 65% | 74% | 25% |
Phonophobia | 43% | 65% | 79% | 25% |
Treatment response | ||||
Oxygen | Yes | No | No | No |
Sumatriptan injection | Yes | Partial | Partial | No |
Indomethacin | No | Yes | Yes | No |
SUNCT = short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing, SUNA = short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms